Jan 22, 2024, 08:54 AM by

Jan 22, 2024, 08:54 AM by

A breakthrough technology PGA brings gene-to-drug revolution in life.

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Montgomeryville, Pennsylvania, January 18, 2024: A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.

Jan 19, 2024, 09:05 AM by

Onyx Scientific plans to drive forward its latest US expansion plans with the appointment of Anthony Harbour as Business Development Manager in North America

Jan 18, 2024, 08:49 AM by

Innovative Technology Accurately Detects Cancer Based on Analysis of Changes to Protein Structure Novo Holdings led growth capital financing

Jan 18, 2024, 08:49 AM by

Kalderos Names Two Industry Veterans to Executive Leadership Roles

Jan 18, 2024, 08:49 AM by

Jan 18, 2024, 08:49 AM by

Jan 18, 2024, 08:49 AM by

Jan 18, 2024, 01:00 AM by User Not Found

Bio-IT World | The lifetime probability of being diagnosed with an invasive cancer is estimated to be roughly 40% for both men and women, and there’s a strong possibility that they are all, in some sense, preventable. Scientific evidence suggests that the body’s immune system copes with the “internal danger” of tumor development the same way it deals with the external threat of infectious diseases.

Jan 17, 2024, 08:41 AM by

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, will exhibit its latest Cell and Gene Therapy (CGT) innovations at Advanced Therapies Week, taking place at the Miami Beach Convention Center from January 16-19.

Jan 17, 2024, 08:41 AM by

Diversified pharmaceutical and life sciences services provider PharmAlliance has acquired Monitorforhire (MFH), the leading web-enabled resource management company connecting professionals with high-impact clinical research opportunities. Operating under BioBridges, PharmAlliance’s talent arm, this acquisition will introduce a new vertical, providing expertise and services to clients and its global network of 4k+ clinical research professionals. Key outcomes include: Bridging Talent Gaps Enhancing Efficiency and Efficacy Strengthening Collaborative Models

Jan 17, 2024, 08:41 AM by

Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly. Vox Imaging is the eighth investment from DPV’s first fund.

Jan 17, 2024, 08:41 AM by

Qlucore has signed an agreement with Sahlgrenska Hospital in Gothenburg, Sweden. The hospital will use the Qlucore Insights software to improve the diagnosis of acute lymphoblastic leukemia (ALL) in children.

Jan 17, 2024, 08:41 AM by